NYSE - Delayed Quote USD

Mirion Technologies, Inc. (MIR)

11.09 +0.08 (+0.73%)
At close: April 26 at 4:00 PM EDT
10.90 -0.19 (-1.71%)
After hours: April 26 at 6:00 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Thomas D. Logan Founder, Medical Group President, CEO & Director 1.87M -- 1961
Mr. Brian Schopfer Chief Financial Officer 1.14M -- 1985
Mr. Loic Eloy Group President of Technologies 626.84k -- 1977
Mr. Christopher Moore CPA Chief Accounting Officer & Principal Accounting Officer -- -- 1972
Mr. James Cocks Chief Technology Officer -- -- --
Mr. Alex Gaddy SVP of Strategy, IR & Treasurer -- -- --
Ms. Emmanuelle Lee Executive VP, General Counsel, Secretary & Chief Legal Officer -- -- --
Erin Schesny Chief Marketing Officer -- -- --
Ms. Alison Ulrich Chief Human Resources Officer -- -- --
Mr. Bertrand Duban President of Nuclear Medicine -- -- --

Mirion Technologies, Inc.

1218 Menlo Drive
Atlanta, GA 30318
United States
770 432 2744 https://www.mirion.com
Sector: 
Industrials
Full Time Employees: 
3,000

Description

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.

Corporate Governance

Mirion Technologies, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 6. The pillar scores are Audit: 8; Board: 5; Shareholder Rights: 6; Compensation: 4.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Apr 30, 2024
Mirion Technologies, Inc. Earnings Call

Related Tickers